PAMIR OZAN (Chief Financial Officer) received a stock award from NIAGEN BIOSCIENCE, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/8/2026ACC: 0001834681-26-000001
Officer· Chief Financial Officer
Since Feb 2026
+4.25K
Net shares
Net buyer
$11.5K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
4.25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.25K
Price / share
$2.71
Trade value
$11.53K
% of position
57.7%
6/30/2026
7.37K→11.63K
Total
Net shares
+4.25K
Net value
$11.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2026 | A · Award | +4.25K | $2.71 | $11.53K | 57.7% | 7.37K | 11.63K |
| Total | +4.25K | $11.53K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.22K
Total
2.22K indirect2.22K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.22K | Indirect |
| Total | 2.22K | 2.22K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported